New imaging tech listens to radiation to improve prostate cancer treatment

NCT ID NCT06465966

Recruiting now Knowledge-focused Sponsor: University of Florida Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a new imaging method called iRAI that uses sound waves to monitor proton radiation delivery in real time for prostate cancer patients. Researchers will compare the actual radiation dose measured by iRAI with the planned dose from CT scans. The goal is to see if iRAI can accurately track where the radiation goes, which could help make treatments more precise. About 30 participants will be enrolled.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ionizing-radiation photo acoustic imaging (iRAI) device
What this could lead to: If successful, this could lead to more precise proton radiation delivery for prostate cancer, potentially reducing side effects.
What could go wrong: This is a small, early-stage feasibility study (30 people) focused on imaging accuracy, not treatment outcomes. The technology may not improve patient results or may have technical limitations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Univeristy of Florida Health Proton Therapy Institute
RECRUITING

Jacksonville, Florida, 32206, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.